Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
NLM DIR Seminar Schedule
UPCOMING SEMINARS
-
Nov. 4, 2025 Mehdi Bagheri Hamaneh
TBD -
Nov. 13, 2025 Leslie Ronish
TBD -
Nov. 18, 2025 Ryan Bell
TBD -
Nov. 24, 2025 Mario Flores
AI Pipeline for Characterization of the Tumor Microenvironment -
Nov. 25, 2025 Jing Wang
TBD
RECENT SEMINARS
-
Oct. 28, 2025 Won Gyu Kim
TBD -
Oct. 21, 2025 Yifan Yang
TBD -
Oct. 14, 2025 Devlina Chakravarty
TBD -
Oct. 9, 2025 Ziynet Nesibe Kesimoglu
TBD -
Oct. 7, 2025 Lana Yeganova
From Algorithms to Insights: Bridging AI and Topic Discovery for Large-Scale Biomedical Literature Analysis.
Scheduled Seminars on Feb. 13, 2024
Contact NLMDIRSeminarScheduling@mail.nih.gov with questions about this seminar.
Abstract:
In this talk, I will present our experience of applying Large Language Models (LLMs) to biomedicine at the BioNLP group. I will first briefly introduce some basics of LLMs, including auto-regressive language modeling, scaling, alignment, few-shot learning, and chain-of-though reasoning. I will share a case study on biomedical question answering for better understanding of these concepts. Despite their great successes, LLMs are known to hallucinate confident-sounding but inaccurate content. In the second part, I will introduce two approaches that augment LLMs to reduce hallucinations in biomedicine, namely retrieval augmentation and tool augmentation. For the former, I will talk about our perspective on how LLMs will impact information seeking from biomedical literature. For the latter, I will present our GeneGPT work for teaching LLMs to use NCBI Web APIs. Finally, with the knowledge gained from the first two parts, I will share our application research, TrialGPT, for patient-to-trial matching with LLMs.